Imdur (Isosorbide Mononitrate) Extended-Release Tablets

The key decision when considering Imdur is whether you need a once-daily extended-release medicine for angina prevention rather than a fast-acting treatment for chest pain that has already started. Imdur contains isosorbide mononitrate and is intended to reduce the occurrence of angina associated with coronary artery disease. It does not work quickly enough to relieve an acute attack. That difference affects how the medicine fits into a treatment plan, how its results are assessed, and whether a separate rescue medicine should be discussed with a prescriber.

What Is Imdur and How Does It Differ From Other Nitrates?

Imdur is an oral extended-release tablet containing isosorbide mononitrate, a nitrate vasodilator used to prevent angina. Its extended-release design provides the active ingredient gradually after a once-daily dose. Official labeling describes this preventive role clearly and states that Imdur is not intended to relieve an acute angina attack.

The release type is an important distinction. Immediate-release isosorbide mononitrate products, including formulations sold under names such as Monoket or Ismo, are generally taken more than once daily on a schedule designed to preserve a period of lower nitrate exposure. Immediate-release isosorbide dinitrate is a related nitrate with a different active ingredient and dosing pattern. Fast-acting forms of Nitroglycerin may be prescribed for an attack in progress, so they serve a different purpose from daily Imdur. These medicines should not be treated as dose-for-dose substitutes.

Who May Consider Imdur?

Imdur may be discussed for adults with coronary artery disease whose prescriber wants to prevent recurring angina rather than manage each episode only after it begins. The decision depends on the complete treatment plan, not simply on how often chest discomfort occurs. Factors to review with a prescriber include:

• Whether the treatment goal is daily prevention rather than rapid relief of sudden symptoms.
• Current blood pressure, dehydration, fainting, or a history of becoming dizzy when standing.
• Other medicines that lower blood pressure or widen blood vessels.
• Pregnancy, because adequate controlled studies in pregnant women are not available and treatment requires an individual benefit-risk decision.
• Breastfeeding, because it is not known whether isosorbide mononitrate passes into human milk.
• Any previous allergic reaction to isosorbide mononitrate, related nitrates, or tablet ingredients.

Safety and effectiveness in children have not been established. Age alone does not rule out treatment in an adult, but older adults may be more susceptible to low blood pressure, dizziness, and falls, especially when other cardiovascular medicines are also used.

How Imdur Works in Daily Treatment

Isosorbide mononitrate is converted within the body to substances that increase nitric oxide signaling in blood vessel walls. This relaxes vascular smooth muscle and widens blood vessels. The effect is greater in veins than in arteries, reducing the amount of blood returning to the heart and lowering the heart's workload. The resulting reduction in oxygen demand helps prevent the supply-and-demand imbalance that can trigger angina.

Continuous nitrate exposure can make the body less responsive over time. Taking extended-release Imdur in the morning, as commonly directed, allows its effect to decrease later in the dosing cycle and helps preserve a daily period of lower nitrate exposure. The dose and timing should follow the prescriber's instructions rather than being moved around to match symptoms. Taking an extra dose during chest pain will not turn the extended-release tablet into a rescue treatment and may cause an unsafe drop in blood pressure.

Taking Imdur Consistently

Extended-release tablets must retain their release characteristics to work as intended. A practical routine usually includes these steps:

1. Take the prescribed dose at the same time each day, commonly in the morning.
2. Swallow the tablet with water. Do not crush or chew it. Split a tablet only if the specific tablet is scored and a prescriber or pharmacist has confirmed that splitting is appropriate.
3. Follow the same food instructions each day instead of frequently switching between taking it with and without food.
4. If a dose is missed, follow the instructions supplied with the medicine or contact a prescriber or pharmacist. Do not take two doses together unless specifically instructed.
5. Store the tablets at 77°F; excursions from 59°F to 86°F are permitted.

Do not change the strength or stop treatment solely because headaches occur. Headache is common with nitrate treatment and may improve as the body adjusts, but severe, persistent, or unusual symptoms should be discussed with a clinician. A prescriber can advise whether symptom management or a treatment change is appropriate.

Available Strengths and Package Choices

Our current Imdur listing includes 20 mg, 30 mg, 40 mg, and 60 mg extended-release tablets. Available package quantities range from 30 to 360 tablets, although the quantities offered vary by strength. Select only the strength directed by your prescriber; tablets with different strengths are not interchangeable simply because they contain the same active ingredient.

Package size is a separate purchasing decision. A smaller quantity may be more appropriate when a dose is still being reviewed, while a larger quantity may be practical after the dose and routine are established. Before choosing, consider the prescribed daily quantity, the follow-up schedule, the medicine's expiration information, and whether the prescriber expects the dose to change. These practical considerations should not be used to override a clinical dose adjustment.

What Results and Timing Should You Expect?

Imdur is assessed by its preventive effect, such as whether angina occurs less often or activity becomes less likely to trigger symptoms. It is not expected to produce the rapid sensation of relief associated with fast-acting Nitroglycerin. A single dose therefore should not be judged by whether it stops pain that is already present.

Keep track of when symptoms occur, what activity preceded them, how long they last, and whether a prescribed rescue medicine was needed. This information can help a prescriber assess the treatment plan. Do not independently increase the dose if the benefit seems to fade, because greater nitrate exposure can worsen headache, dizziness, and low blood pressure without restoring the intended effect.

New, worsening, persistent, or unusually severe chest pain requires prompt medical assessment. Follow the emergency plan provided by your clinician, and seek emergency help for symptoms that may represent a heart attack. Imdur should never be used to delay urgent care.

Important Safety Priorities

The most important preventable risk is combining Imdur with a phosphodiesterase type 5 inhibitor, often called a PDE5 inhibitor. This group includes medicines used for erectile dysfunction or pulmonary hypertension. Soluble guanylate cyclase stimulators such as riociguat also interact dangerously with nitrates. Either combination can cause a severe and sudden fall in blood pressure. A prescriber needs to know about all prescription medicines, nonprescription medicines, and supplements before Imdur is started.

Imdur also requires particular caution in people with very low blood pressure, reduced blood volume, or a previous allergic reaction to isosorbide mononitrate or related nitrate medicines. Dizziness and lightheadedness may occur, especially after standing up, when treatment begins, or after the dose changes. Do not drive or operate machinery until you know how the medicine affects you.

Use the checklist to organize a discussion with your prescriber or pharmacist before the first dose. It is not a substitute for individualized advice, particularly when several medicines affect blood pressure or when pregnancy, breastfeeding, fainting, or recurring severe headaches are relevant.

Interactions and Practical Precautions

Several everyday factors can increase the blood-pressure-lowering effects of Imdur:

• Alcohol may worsen dizziness, lightheadedness, and fainting.
• Beta blockers, calcium channel blockers, and other blood pressure medicines may have additive effects. These combinations are sometimes prescribed intentionally but require clinical oversight.
• Diuretics and conditions that reduce body fluid volume may make a sudden blood pressure drop more likely.
• Standing up slowly and holding onto a stable surface may reduce the chance of losing balance when dizziness occurs.
• Heat, prolonged standing, vomiting, or diarrhea may contribute to dehydration and make lightheadedness more noticeable.

Diabetes is not a specific contraindication to isosorbide mononitrate, but all current medicines should still be reviewed because a person may be using several cardiovascular treatments at once. Before taking any medicine for erectile dysfunction or pulmonary hypertension, explicitly tell the prescriber that you use a nitrate; relying only on a general medication list can leave a serious interaction overlooked.

Is Imdur the Right Choice Compared With Other Options?

No single antianginal medicine is best for everyone. The useful comparison is based on the intended role, release type, dosing routine, heart rate, blood pressure, other conditions, and side-effect history:

• Monoket or Ismo: immediate-release isosorbide mononitrate formulations may be used more than once daily. They contain the same active ingredient as Imdur but have different release and dosing characteristics.
• Isosorbide dinitrate: this is a related nitrate with a different active ingredient. Immediate-release preparations are generally taken more frequently and are not dose-for-dose equivalents of Imdur.
• Nitroglycerin: fast-acting forms are commonly used for an angina attack already in progress. A prescriber may recommend one alongside a preventive medicine rather than as a direct replacement for it.
• Metoprolol, atenolol, or bisoprolol: these beta blockers reduce heart rate and cardiac workload. They may be used instead of or with a nitrate, depending on heart rate, blood pressure, and tolerance.
• Amlodipine: this calcium channel blocker relaxes blood vessels and may be considered alone or as part of combination treatment when clinically appropriate.

Headache or low blood pressure may limit nitrate treatment, while a low heart rate or certain other conditions may affect whether a beta blocker is suitable. These tradeoffs require an individualized clinical decision. Readers comparing broader cardiovascular options can also review our blood pressure category and heart disease category.

US Prescription Status and Our Ordering Policy

Imdur is a prescription-only medicine in the United States. FDA-approved labeling identifies it as an extended-release nitrate for preventing angina caused by coronary artery disease and not for treating an acute attack. The FDA approval record for NDA 020215 identifies 30 mg, 60 mg, and 120 mg Imdur tablets; that regulatory record should not be read as a list of every strength in our current product listing.

Our ordering policy does not require customers to submit a prescription when placing an order. Our policy does not change the medicine's prescription-only status in the United States or the need to use it under the direction of a licensed prescriber. Confirm the prescribed product, strength, and directions before ordering.

Ordering and Support From Our Team

We offer Imdur in the listed strengths and package quantities, with prices shown in US dollars. Match the selected strength to the prescriber's instructions and check the tablet count separately; choosing a larger quantity does not make a different strength equivalent. Our customer support team is available 24/7 by email, online chat, and phone, and pharmacist support is also available for product-related questions. We have operated since 2017.

Use support for questions about the product listing or available package choices, but direct personal treatment questions to an appropriate prescriber or pharmacist. No delivery time or guaranteed arrival date is supplied in the current product information, so none should be assumed when planning a refill. Allow enough time to avoid interrupting treatment, and do not compensate for a delayed refill by changing how remaining doses are taken.

A Focused Final Decision

Imdur is a logical product to discuss when the intended treatment is a once-daily oral extended-release nitrate for preventing angina. It is not the appropriate choice when the immediate need is relief of an attack already in progress. Before ordering, confirm the product name, prescribed strength, daily timing, current medication list, and plan for sudden symptoms. Once those clinical points are settled, the remaining purchasing decision is to select an available package quantity that fits the established regimen.